Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Billionaire Ray Dalio and Insiders Love These 10 Stocks

In this article, we will take a detailed look at Billionaire Ray Dalio and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Ray Dalio and Insiders Love These 5 Stocks.

Investors are on tenterhooks before the latest inflation report scheduled to be out on Tuesday. While many believe a more-than-expected uptick in prices could further derail the Fed’s plan of action regarding rate hikes, the bulls believe the market is set for further gains in 2024 and beyond as stocks continue to rage higher and market gains that were once concentrated in a few names are now rewarding other companies as well. A latest Wall Street Journal report cited data from Bespoke Investment Group, which showed that the equal-weighted S&P 500 rose to a record high last week, as about one-fifth of the stocks in the index hit new 52-week highs.

The WSJ report also quoted Joseph Amato, chief investment officer of Neuberger Berman, who said that risky assets could perform well as inflation is coming down and the Fed is “no longer fighting you.”

Market Gains are Broadening Out

Scott Chronert, Citi U.S. equity strategist, who has been bullish on the S&P 500 fundamentals for several weeks now, recently said in a program on CNBC that there is a lot to support his bullish view on the market. The analyst said while the Magnificent Seven group of stocks certainly contributed to the market rally, the “broadening” of the rally to other stocks is also playing a key role in the bull run. Chronert said that after being on the sidelines for most part of 2023, investors are now trying to join the market rally since he believes inflows in ETFs are growing. The analyst also said the generative AI growth drivers are still pulling the Magnificent Seven tech stocks. Chronert expects the S&P 500 to touch 5,700 this year based on his bullish case assumptions.

Methodology

In this backdrop, when market experts are expecting further growth in the stock market, it’s important to see which stocks insiders and hedge funds are buying. For this article we used Insider Monkey’s stock screener to first list down the stocks that have seen heavy insider buying activity over the past few months. From these stocks we selected 10 stocks in which billionaire Ray Dalio’s Bridgewater Associates has stakes, based on the fund’s Q4’2023 portfolio. Some top names in the list are Exxon Mobil Corp (NYSE:XOM), Enphase Energy Inc (NASDAQ:ENPH) and Block Inc (NYSE:SQ). The idea was to find stocks that both Ray Dalio and corporate insiders love. But why is it important to keep tabs on hedge fund activity? Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here).

Billionaire Ray Dalio and Corporate Insiders are Loading Up on These Stocks

10. CNX Resources Corp (NYSE:CNX)

Bridgewater Associates’ Stake: $1,084,440

Bridgewater Associates reported owning a $1 million stake in CNX Resources Corp (NYSE:CNX) as of the end of the fourth quarter of 2023. This was a 68% decline in the fund’s stake in CNX Resources Corp (NYSE:CNX) when compared to the previous quarter. Bernard Lanigan, a board member at CNX Resources Corp (NYSE:CNX), amassed 172,830 shares of CNX Resources Corp (NYSE:CNX) on June 30, 2023, at  $21.25 per share. Since then, the stock has gained about 19% in value through March 8. In addition to CNX, hedge funds also like Exxon Mobil Corp (NYSE:XOM), Enphase Energy Inc (NASDAQ:ENPH) and Block Inc (NYSE:SQ).

Longleaf Partners Small-Cap Fund made the following comment about CNX Resources Corporation (NYSE:CNX) in its Q3 2023 investor letter:

“CNX Resources Corporation (NYSE:CNX) – Natural gas company CNX Resources was the top performer in the quarter. The company benefited from rising energy prices, as well as strong operational execution. CNX remains highly discounted, as the market does not give the company credit for its longer-term undrilled assets or its “new technology investments,” which include methods to reduce carbon on a net basis. Management expects this to be a material business for CNX over the longer term, but for now it is a high-quality hidden asset. CNX has taken advantage of the price disconnect through meaningful share repurchase.”

9. Block Inc (NYSE:SQ)

Bridgewater Associates’ Stake: $1,356,719

As of the end of the last quarter of 2023, Ray Dalio’s hedge fund reported owning 17,540 shares of Block Inc (NYSE:SQ). On November 8, Roelof Botha, a board director at the payments company, snapped up 540,646 shares of Block Inc (NYSE:SQ) at $50.89 per share. Since then, the stock has gained about 47% in value as of March 8.

As of the end of the fourth quarter of 2023, 75 hedge funds tracked by Insider Monkey had stakes in Block Inc (NYSE:SQ). The biggest sake in Block Inc (NYSE:SQ) is owned by Catherine D. Wood’s ARK Investment Management which owns a $920 million stake in Block Inc (NYSE:SQ).

Baron Fifth Avenue Growth Fund stated the following regarding Block, Inc. (NYSE:SQ) in its fourth quarter 2023 investor letter:

“During the quarter, we also added to our existing investment in Block, Inc. (NYSE:SQ). The company provides a point-of-sale technology to small businesses and operates the Cash App ecosystem of financial services for individuals. After the company reported solid quarterly result, it has also guided to reach a rule of 40 on GAAP profitability for fiscal year 2026 (implying that the combination of gross profit growth and GAAP operating margins would be at least 40%). We believe Block’s businesses are resilient, and greater management focus on cost discipline should drive further margin expansion over the long term. We also believe that Block has a long runway for growth, durable competitive advantages, and a robust track record of innovation.”

8. Transocean LTD (NYSE:RIG)

Bridgewater Associates’ Stake: $1,741,132

American drilling company Transocean LTD (NYSE:RIG) is a new addition in Ray Dalio’s portfolio since Bridgewater bought $1.7 million worth of Transocean LTD (NYSE:RIG) shares during the last quarter of 2023. On February 27, Frederik Wilhelm Mohn, a director at Transocean LTD’s (NYSE:RIG) board, bought one million shares of Transocean LTD (NYSE:RIG) at $4.89 per share. Since then the stock has gained about 6.6% in value.

7. Keurig Dr Pepper Inc. (NASDAQ:KDP)

Bridgewater Associates’ Stake: $1,907,004

Beverage company Keurig Dr Pepper Inc. (NASDAQ:KDP) ranks seventh in our list of the stocks both Ray Dalio and Insiders love. Keurig Dr Pepper Inc.’s (NASDAQ:KDP) CEO  Robert Gamgort on March 5 bought 171,821 Keurig Dr Pepper Inc. (NASDAQ:KDP) shares at $29.10 per share. Two directors at Keurig Dr Pepper Inc.’s (NASDAQ:KDP) board also bought 171,821 shares each at the same price. Since March 5 through market close on March 7 the stock jumped 1.39%.

6. Sarepta Therapeutics Inc (NASDAQ:SRPT)

Bridgewater Associates’ Stake: $2,544,595

Ray Dalio’s Bridgewater decreased its stake Sarepta Therapeutics Inc (NASDAQ:SRPT) by 48% in the fourth quarter of 2023, concluding the year with a $2.5 million stake in the Massachusetts-based medical research and drug development company. Richard Barry, a director at Sarepta Therapeutics Inc’s (NASDAQ:SRPT) board, bought 50,000 shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) on November 3 at $78.81 per share. As of March 7 market close the stock was trading at around $120.78 per share. This shows a whopping 53% increase in stock price. In addition to SRPT, insiders are also piling into Exxon Mobil Corp (NYSE:XOM), Enphase Energy Inc (NASDAQ:ENPH) and Block Inc (NYSE:SQ).

Bronte Capital Amalthea Fund made the following comment about Sarepta Therapeutics, Inc. (NASDAQ:SRPT) in its Q3 2023 investor letter:

“The FDA is widely considered to be the world’s foremost regulator of drug products, with a stringent and rigorous process for evaluating new marketing applications. Disagreements between the FDA and regulators in other developed markets (such as the European Medicines Agency or the Australian Therapeutic Goods Administration (TGA)) are rare, and when they do occur, it is usually because the FDA has taken a more critical view of the applicant’s evidence.

For a drug to be approved in the US, it must meet the statutory requirement of “substantial evidence of effectiveness” under the Federal Food, Drug, and Cosmetic Act. There are essentially three ways to meet this requirement. Normally, the FDA expects the sponsor to succeed in two “adequate and well-controlled studies”. Alternatively, the sponsor can rely on success from a single study if the results from that study are “very persuasive”, or if they are combined with some sort of independent confirmatory evidence. For the most part lobbying from the cohort of patients, the “patient voice”, has played a relatively minor role in the FDA’s decision-making process and the agency has been prepared to make tough but rational decisions when the “substantial evidence” standard is clearly not met.

However, this was not the case in 2016 when the FDA famously overruled its own review team and external advisory committee to approve Sarepta Therapeutics, Inc.’s (NASDAQ:SRPT) controversial drug for Duchenne muscular dystrophy (Exondys 51). At the time, Sarepta had completed a single phase 2 trial in just 12 patients which, per the FDA Commissioner (Robert Califf) himself, had “major flaws” in both its design and conduct. Ellis Unger, director of the Office of Drug Evaluation at the FDA, declared that the drug was a “scientifically elegant placebo”, and that patients and their families were taking on unknown risks for likely non-existent benefits…” (Click here to read the full text)

Click to continue reading and see Billionaire Ray Dalio and Insiders Love These 5 Stocks.

Suggested Articles:

Disclosure. None. Billionaire Ray Dalio and Insiders Love These 10 Stocks was initially published on Insider Monkey.

AI, Tariffs, Nuclear Power: One Undervalued Stock Connects ALL the Dots (Before It Explodes!)

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

AI is eating the world—and the machines behind it are ravenous.

Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink.

Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and building the digital future. But there’s one urgent question few are asking:

Where will all of that energy come from?

AI is the most electricity-hungry technology ever invented. Each data center powering large language models like ChatGPT consumes as much energy as a small city. And it’s about to get worse.

Even Sam Altman, the founder of OpenAI, issued a stark warning:

“The future of AI depends on an energy breakthrough.”

Elon Musk was even more blunt:

“AI will run out of electricity by next year.”

As the world chases faster, smarter machines, a hidden crisis is emerging behind the scenes. Power grids are strained. Electricity prices are rising. Utilities are scrambling to expand capacity.

And that’s where the real opportunity lies…

One little-known company—almost entirely overlooked by most AI investors—could be the ultimate backdoor play. It’s not a chipmaker. It’s not a cloud platform. But it might be the most important AI stock in the US owns critical energy infrastructure assets positioned to feed the coming AI energy spike.

As demand from AI data centers explodes, this company is gearing up to profit from the most valuable commodity in the digital age: electricity.

The “Toll Booth” Operator of the AI Energy Boom

  • It owns critical nuclear energy infrastructure assets, positioning it at the heart of America’s next-generation power strategy.
  • It’s one of the only global companies capable of executing large-scale, complex EPC (engineering, procurement, and construction) projects across oil, gas, renewable fuels, and industrial infrastructure.
  • It plays a pivotal role in U.S. LNG exportation—a sector about to explode under President Trump’s renewed “America First” energy doctrine.

Trump has made it clear: Europe and U.S. allies must buy American LNG.

And our company sits in the toll booth—collecting fees on every drop exported.

But that’s not all…

As Trump’s proposed tariffs push American manufacturers to bring their operations back home, this company will be first in line to rebuild, retrofit, and reengineer those facilities.

AI. Energy. Tariffs. Onshoring. This One Company Ties It All Together.

While the world is distracted by flashy AI tickers, a few smart investors are quietly scooping up shares of the one company powering it all from behind the scenes.

AI needs energy. Energy needs infrastructure.

And infrastructure needs a builder with experience, scale, and execution.

This company has its finger in every pie—and Wall Street is just starting to notice.

Wall Street is noticing this company also because it is quietly riding all of these tailwinds—without the sky-high valuation.

While most energy and utility firms are buried under mountains of debt and coughing up hefty interest payments just to appease bondholders…

This company is completely debt-free.

In fact, it’s sitting on a war chest of cash—equal to nearly one-third of its entire market cap.

It also owns a huge equity stake in another red-hot AI play, giving investors indirect exposure to multiple AI growth engines without paying a premium.

And here’s what the smart money has started whispering…

The Hedge Fund Secret That’s Starting to Leak Out

This stock is so off-the-radar, so absurdly undervalued, that some of the most secretive hedge fund managers in the world have begun pitching it at closed-door investment summits.

They’re sharing it quietly, away from the cameras, to rooms full of ultra-wealthy clients.

Why? Because excluding cash and investments, this company is trading at less than 7 times earnings.

And that’s for a business tied to:

  • The AI infrastructure supercycle
  • The onshoring boom driven by Trump-era tariffs
  • A surge in U.S. LNG exports
  • And a unique footprint in nuclear energy—the future of clean, reliable power

You simply won’t find another AI and energy stock this cheap… with this much upside.

This isn’t a hype stock. It’s not riding on hope.

It’s delivering real cash flows, owns critical infrastructure, and holds stakes in other major growth stories.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 100+% Return within 12 to 24 months.

We’re now offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $9.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…